116 related articles for article (PubMed ID: 37403385)
1. The Neuroanatomical Basis of the 5-HT Syndrome and Harmalineinduced Tremor.
Lalonde R; Strazielle C
Curr Rev Clin Exp Pharmacol; 2024; 19(2):163-172. PubMed ID: 37403385
[TBL] [Abstract][Full Text] [Related]
2. The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat.
Dickinson SL; Andrews CD; Curzon G
Neuropharmacology; 1984 Apr; 23(4):423-9. PubMed ID: 6728129
[TBL] [Abstract][Full Text] [Related]
3. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
4. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
Trulson ME; Eubanks EE; Jacobs BL
J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
[TBL] [Abstract][Full Text] [Related]
5. Veratramine-induced behavior associated with serotonergic hyperfunction in mice.
Nagata R; Izumi K
Jpn J Pharmacol; 1991 Jan; 55(1):129-37. PubMed ID: 1710297
[TBL] [Abstract][Full Text] [Related]
6. The comparative pharmacology of the behavioral syndromes induced by TRH and by 5-HT in the rat.
Pranzatelli MR
Gen Pharmacol; 1988; 19(2):205-11. PubMed ID: 2895033
[TBL] [Abstract][Full Text] [Related]
7. High-dose clonidine motor syndrome: relationship to serotonin syndrome.
Pranzatelli MR; Schultz L; Snodgrass SR
Behav Brain Res; 1987 Jun; 24(3):221-32. PubMed ID: 2886133
[TBL] [Abstract][Full Text] [Related]
8. The functional significance of neonatal 5,7-dihydroxytryptamine lesions in the rat: response to selective 5-HT1A and 5-HT2,1C agonists.
Pranzatelli MR; Dollison AM; Huang YY
Brain Res Bull; 1990 Jun; 24(6):747-53. PubMed ID: 2142615
[TBL] [Abstract][Full Text] [Related]
9. Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of spinal 5-hydroxytryptamine by 5,7-dihydroxytryptamine administered into various sites.
Sawynok J; Reid A
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):1-8. PubMed ID: 2402297
[TBL] [Abstract][Full Text] [Related]
10. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
Fone KC; Robinson AJ; Marsden CA
Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
[TBL] [Abstract][Full Text] [Related]
12. [Effect of long-term lithium treatment on serotonin syndrome in rats].
Yamawaki S; Yanagawa K; Hotta I; Uchitomi Y
Yakubutsu Seishin Kodo; 1986 Jun; 6(2):247-52. PubMed ID: 3096011
[TBL] [Abstract][Full Text] [Related]
13. The indolaminergic innervation of the inferior olive. 2. Relation to harmaline induced tremor.
Sjölund B; Björklund A; Wiklund L
Brain Res; 1977 Aug; 131(1):23-37. PubMed ID: 884545
[TBL] [Abstract][Full Text] [Related]
14. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
Howe JR; Yaksh TL
J Pharmacol Exp Ther; 1982 Feb; 220(2):311-21. PubMed ID: 6120226
[TBL] [Abstract][Full Text] [Related]
15. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
Smith LM; Peroutka SJ
Pharmacol Biochem Behav; 1986 Jun; 24(6):1513-9. PubMed ID: 2942947
[TBL] [Abstract][Full Text] [Related]
17. EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive.
Milner TE; Cadoret G; Lessard L; Smith AM
J Neurophysiol; 1995 Jun; 73(6):2568-77. PubMed ID: 7666163
[TBL] [Abstract][Full Text] [Related]
18. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
Pranzatelli MR; Snodgrass SR
Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
[TBL] [Abstract][Full Text] [Related]
19. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
Pranzatelli MR; Snodgrass SR
Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
[TBL] [Abstract][Full Text] [Related]
20. Role of 5-HT(1A)- and 5-HT(2A) receptors for the murine model of the serotonin syndrome.
Haberzettl R; Fink H; Bert B
J Pharmacol Toxicol Methods; 2014; 70(2):129-33. PubMed ID: 25087754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
